Saamya Biotech (India) Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, loss from operations before other income, finance costs and exceptional items was INR 839,239 compared to loss from operations before other income, finance costs and exceptional items of INR 762,494 a year ago. Loss from ordinary activities before tax was INR 852,910 compared to loss ordinary activities before tax of INR 805,612 a year ago. Loss for the period was INR 850,758 or INR 0.03 per basic and diluted share compared to loss for the period of INR 733,567 or INR 0.03 per basic and diluted share a year ago.

For the nine months, loss from operations before other income, finance costs and exceptional items was INR 3,237,919 compared to loss from operations before other income, finance costs and exceptional items of INR 1,413,862 a year ago. Loss from ordinary activities before tax was INR 3,336,668 compared to loss ordinary activities before tax of INR 1,639,917 a year ago. Loss for the period was INR 3,330,006 or INR 0.13 per basic and diluted share compared to loss for the period of INR 1,673,052 or INR 0.07 per basic and diluted share a year ago.